Sign in

CIK 0001604821 · Large accelerated filer

Natera, Inc.

Sign in to watch
Ticker
NTRA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
010894487
Phone
650-249-9090
Business address
13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
Former names
Natera, Inc.
  1. 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 1,861 shares at an average $204.09 ($379,811)
  2. 4 Planned sale Director sold 3,544 shares at an average $197.43 ($699,693)
  3. 144 Insider Sale of Securities
  4. 4 Grant or award Director acquired 339 shares (grant or award)
  5. 4 Grant or award Director acquired 330 shares (grant or award)
  6. 4 Grant or award Director acquired 336 shares (grant or award)
  7. 4 Grant or award Director acquired 354 shares (grant or award)
  8. 4 Grant or award Director acquired 5 shares (grant or award)
  9. 4 Grant or award Director acquired 86 shares (grant or award)
  10. 4 Grant or award Director acquired 83 shares (grant or award)
  11. 4 Grant or award Director acquired 83 shares (grant or award)
  12. ARS Other Annual Report to Security Holders
  13. DEFA14A Proxy Proxy Materials
  14. DEF 14A Proxy Proxy Statement
  15. 4 Planned sale Director sold 1,500 shares at an average $199.63 ($299,441)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Shares withheld for taxes EXECUTIVE CHAIRMAN gave up 27,610 shares (to pay taxes)
  18. 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 8,400 shares at an average $203.31 ($1,707,814)
  19. 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 3,000 shares at an average $202.30 ($606,899)
  20. 4 Option exercise EXECUTIVE CHAIRMAN acquired 41,708 shares (option exercise)

Page 10 of 94 · 1,862 filings